Quick Takeaways
- ARMISTICE CAPITAL, LLC has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $87,590,001.
- Recent insider filing activity is available below.
- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of ARMISTICE CAPITAL, LLC
- Location
- New York, NY
- Summary
- The estimated value of insider holdings of ARMISTICE CAPITAL, LLC is at least $87,590,001 dollars as of 28 Jun 2023. ARMISTICE CAPITAL, LLC is the 10%+ Owner of ReShape Lifesciences Inc. and owns shares of Vyome Holdings, Inc (HIND) stock worth about $79.17M. ARMISTICE CAPITAL, LLC is the Director of AYTU BIOPHARMA, INC and owns shares of AYTU BIOPHARMA, INC (AYTU) stock worth about $5.02M. ARMISTICE CAPITAL, LLC is the 10%+ Owner of EYEGATE PHARMACEUTICALS INC and owns shares of KIORA PHARMACEUTICALS INC (KPRX) stock worth about $3.01M. ARMISTICE CAPITAL, LLC is the 10%+ Owner of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $397.8K.
- Signature
- ARMISTICE CAPITAL, LLC, Name: /s/ Steven Boyd, Title: Managing Member
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow ARMISTICE CAPITAL, LLC and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ReShape Lifesciences Inc. ($79,167,872).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of ARMISTICE CAPITAL, LLC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| HIND | ReShape Lifesciences Inc. | 10%+ Owner | $79,167,872 | 28 Jun 2021 | ||
| AYTU | AYTU BIOPHARMA, INC | Director | $5,017,808 | 20 Mar 2021 | ||
| KPRX, KPHMW | EYEGATE PHARMACEUTICALS INC | 10%+ Owner | $3,006,550 | 30 Jul 2021 | ||
| AVTX | Avalo Therapeutics, Inc. | 10%+ Owner | $397,771 | 26 Jun 2023 | ||
| RSLS | ReShape Weightloss Inc. | 10%+ Owner | 15 Jun 2021 | |||
| TENX | TENAX THERAPEUTICS, INC. | Director | 18 May 2022 |
Insider Transactions Reported by ARMISTICE CAPITAL, LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.